US Stock MarketDetailed Quotes

Xeris Pharmaceuticals (XERS)

Watchlist
  • 6.930
  • +0.220+3.28%
Close Jun 11 15:59 ET
  • 7.044
  • +0.114+1.64%
Post 19:48 ET
1.20BMarket Cap94.93P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xeris Pharmaceuticals (XERS) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Recorlev49.77M59.87%
Gvoke20.8M25.02%
Keveyis11.89M14.30%
Royalty, contract and other revenue673K0.81%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States291.85M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.48%
Sample Name
Sample Code
 +1.20%
Sample Name
Sample Code
 -2.64%
4
ProShares Ultra Energy
DIG
-2.80%
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
-2.93%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +6.08%
Sample Name
Sample Code
 +3.63%
Sample Name
Sample Code
 +3.45%
4
Amer Sports
AS
+3.22%
5
NetEase
NTES
+2.95%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th, Eastern Time, Trump stated he would launch a military strike against Iran that evening, targeting core oil facil Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -